Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:299-302

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Douglas, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Douglas, P. S.

(Circulation. 1997;95:299-302.)
© 1997 American Heart Association, Inc.


Articles

Is Noninvasive Testing for Coronary Artery Disease Accurate?

Pamela S. Douglas, MD

the Cardiovascular Division, Beth Israel Hospital, Harvard Medical School, Harvard-Thorndike Laboratory, Boston, Mass.

Correspondence to Pamela S. Douglas, MD, Cardiovascular Division, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215. E-mail pdouglas@bih.harvard.edu


Key Words: Editorials • diagnosis • tests


*    Introduction
 
Since the measuring device has been constructed by the observer . . . we have to remember that what we observe is not nature in itself but nature exposed to our method of questioning.

Werner Karl Heisenberg

Physics and Philosophy, 1958

Diagnostic testing forms an important component of cardiovascular medicine, such that optimal practice requires detailed knowledge of how to use and interpret tests. Methods of describing test performance, such as sensitivity and specificity, are widely used with the assumption that they are fairly constant descriptors of the ability of a given test result to detect the presence or absence of disease. Unfortunately, while such concepts are fundamental, accurate assessment of test performance is far more complex, and many factors significantly affect test performance.

In the initial evaluation of a test, investigators often assess its performance by comparing results in populations with very low and very high likelihoods of disease—such as healthy volunteers and afflicted patients. The test in question appears to be an excellent discriminator, although the clinically relevant question of correctly classifying a patient with an intermediate probability of disease has not been addressed. Nevertheless, the published results will indicate very high sensitivity and specificity of the test. However, in subsequent test assessments based on wider use of the test in less clearly segregated populations, they appear to plummet.1 The accuracy of the test has not changed; rather, the population referred for testing has. Thus, apparent test performance can be altered by referral patterns or pretest selection bias. Related to . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CirculationHome page
J. H. Mieres, L. J. Shaw, A. Arai, M. J. Budoff, S. D. Flamm, W. G. Hundley, T. H. Marwick, L. Mosca, A. R. Patel, M. A. Quinones, et al.
Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease: Consensus Statement From the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association
Circulation, February 8, 2005; 111(5): 682 - 696.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. V. Williams, S. D. Fihn, and R. J. Gibbons
Guidelines for the Management of Patients with Chronic Stable Angina: Diagnosis and Risk Stratification
Ann Intern Med, October 2, 2001; 135(7): 530 - 547.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Pfohl, M. Koch, S. Prescod, K.K. Haase, H.U. Haring, and K.R. Karsch
Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study
Eur. Heart J., September 2, 1999; 20(18): 1318 - 1325.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al.
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197.
[Full Text] [PDF]


Home page
HeartHome page
M-D Enderle, S Schroeder, R Ossen, C Meisner, A Baumbach, H U Haering, K R Karsch, and M Pfohl
Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease
Heart, October 1, 1998; 80(4): 349 - 354.
[Abstract] [Full Text]


Home page
CirculationHome page
L. Mosca, J. E. Manson, S. E. Sutherland, R. D. Langer, T. Manolio, E. Barrett-Connor, and E. Barrett-Connor
Cardiovascular Disease in Women : A Statement for Healthcare Professionals From the American Heart Association
Circulation, October 7, 1997; 96(7): 2468 - 2482.
[Full Text]